Elanco Animal Health Incorporated (ELAN)
NYSE
22.54
+0.18 (+0.81%)
Closed
Oct 8, 2026
Day's Range
22.0022.63
52 wk Range
19.4027.98
Financial Statements - ELAN - Elanco Animal Health Incorporated
Revenue
4.71B▲ 6.2%
Net Income
-232.00M▼ 168.6%Net Margin -4.9%
EBITDA
913.00M▲ 2.0%
Free Cash Flow
284.00M▼ 25.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 4.71B | 4.43B | 4.41B | 4.41B | 4.76B | 3.27B |
| Cost of Goods | 2.12B | 2B | 1.93B | 1.91B | 2.13B | 1.66B |
| Gross Profit | 2.59B | 2.43B | 2.48B | 2.49B | 2.63B | 1.60B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 252M | 251M | 326M | 384M | 304M | -82M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -256M | 472M | -1.24B | -215M | -639M | -445M |
| Pre Tax Income | -224M | 488M | -1.19B | -72M | -571M | -677M |
| Income Tax | 8M | 150M | 36M | 6M | -88M | -103M |
| Net Income | -232M | 338M | -1.23B | -78M | -483M | -574M |
| EPS Basic | -0.47 | 0.68 | -2.5 | -0.15 | -0.97 | -1.27 |
| EPS Diluted | -0.47 | 0.68 | -2.5 | -0.15 | -0.97 | -1.27 |
| Basic Shares Outstanding | 496.40M | 494M | 492.30M | 488.30M | 487.20M | 441.40M |
| Diluted Shares Outstanding | 496.40M | 494M | 492.30M | 488.30M | 487.20M | 441.40M |
| Ebit | -4M | 723M | -918M | 169M | -335M | -527M |
| Ebitda | 913M | 895M | 945M | 1.03B | 1.01B | 613M |
| Net Income Continuous Operations | -232M | 338M | -1.23B | -78M | -483M | -574M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
